Revasol

RevaSol is a medical technology company focused on the development and commercialization of advanced sorbent-based systems for blood purification and dialysis. Founded by Dr. Stephen R. Ash, a pioneer in nephrology, the company specializes in portable and wearable dialysis solutions that utilize sorbent chemicals to regenerate dialysate, significantly reducing the water requirements of traditional hemodialysis. RevaSol's technology is designed to improve the quality of life for patients with end-stage renal disease (ESRD) and acute liver failure by providing more flexible and efficient treatment options. The company operates as part of a cluster of firms, including HemoCleanse and Ash Access Technology, dedicated to innovative extracorporeal therapies.